CVS, PBM and Health

'Health insurance companies are always going to need a PBM': CVS president Prem Shah
A reescalating battle between pharmaceutical companies and pharmacy benefit managers is brewing in Washington, D.C., as President Donald Trump's new administration takes shape. The drug industry's biggest lobbying firm,
CVS Health appoints CVS Caremark president
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
CVS taps Ed DeVaney to lead its Caremark PBM
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim president of Caremark since December 2024. The president's role was vacated when David Joyner took over as CEO of CVS Health in October.
CVS Health names DeVaney as President of CVS Caremark
CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president
CVS Health names Ed DeVaney president of PBM business
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS names PBM president
CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS Health.
CVS names new chief executive for Caremark PBM division
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management business.
Investor's Business Daily on MSN6h
CVS Health Stock Gets RS Rating Upgrade
CVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video ...
Modern Healthcare3h
CVS Health, Emory expand MinuteClinic primary care services
A CVS spokesperson said the Emory collaboration is the first time MinuteClinic has expanded into primary care services in ...
CVS Health: One Good Quarter Is Not Enough; Retain Sell
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
CVS Health Is About to Report Q4 Earnings Tomorrow. Here’s What to Expect
Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...
CVS Health steers through rising insurance costs in a strong fourth quarter
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...
Modern Healthcare1d
FTC's insulin case against UnitedHealth, CVS, Cigna PBMs advances
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
Principal Securities Inc. Acquires 859 Shares of CVS Health Co. (NYSE:CVS)
Principal Securities Inc. grew its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 3.2% during the fourth ...
Is CVS Health's Dividend Safe?
It's also worth pointing out that CVS Health seems to have plenty of space to increase its dividend. The company's cash ...
CVS Health Corp. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...